| Product Code: ETC11640240 | Publication Date: Apr 2025 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
In 2024, Togo continued to heavily rely on imports of Chronic Obstructive Pulmonary Disorder products, with top exporters being France, India, China, USA, and Denmark. Despite a high concentration with the Herfindahl-Hirschman Index remaining elevated, the industry experienced a concerning decline with a negative Compound Annual Growth Rate (CAGR) of -2.47% from 2020 to 2024. The growth rate in 2024 saw a further downturn at -8.58%, signaling a challenging market landscape for COPD imports in Togo.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Togo Chronic Obstructive Pulmonary Disorder Market Overview |
3.1 Togo Country Macro Economic Indicators |
3.2 Togo Chronic Obstructive Pulmonary Disorder Market Revenues & Volume, 2021 & 2031F |
3.3 Togo Chronic Obstructive Pulmonary Disorder Market - Industry Life Cycle |
3.4 Togo Chronic Obstructive Pulmonary Disorder Market - Porter's Five Forces |
3.5 Togo Chronic Obstructive Pulmonary Disorder Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.6 Togo Chronic Obstructive Pulmonary Disorder Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.7 Togo Chronic Obstructive Pulmonary Disorder Market Revenues & Volume Share, By Disease Type, 2021 & 2031F |
3.8 Togo Chronic Obstructive Pulmonary Disorder Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Togo Chronic Obstructive Pulmonary Disorder Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic obstructive pulmonary disorder (COPD) in Togo |
4.2.2 Growing awareness about the importance of early diagnosis and treatment of COPD |
4.2.3 Advancements in healthcare infrastructure and facilities for COPD management in Togo |
4.3 Market Restraints |
4.3.1 Limited access to healthcare services in remote areas of Togo |
4.3.2 High cost associated with COPD medications and treatment |
4.3.3 Lack of trained healthcare professionals specializing in COPD management in Togo |
5 Togo Chronic Obstructive Pulmonary Disorder Market Trends |
6 Togo Chronic Obstructive Pulmonary Disorder Market, By Types |
6.1 Togo Chronic Obstructive Pulmonary Disorder Market, By Drug Type |
6.1.1 Overview and Analysis |
6.1.2 Togo Chronic Obstructive Pulmonary Disorder Market Revenues & Volume, By Drug Type, 2021 - 2031F |
6.1.3 Togo Chronic Obstructive Pulmonary Disorder Market Revenues & Volume, By Phosphodiesterase4 Inhibitors, 2021 - 2031F |
6.1.4 Togo Chronic Obstructive Pulmonary Disorder Market Revenues & Volume, By Bronchodilators, 2021 - 2031F |
6.1.5 Togo Chronic Obstructive Pulmonary Disorder Market Revenues & Volume, By Corticosteroids, 2021 - 2031F |
6.1.6 Togo Chronic Obstructive Pulmonary Disorder Market Revenues & Volume, By Combination Therapy, 2021 - 2031F |
6.2 Togo Chronic Obstructive Pulmonary Disorder Market, By Product Type |
6.2.1 Overview and Analysis |
6.2.2 Togo Chronic Obstructive Pulmonary Disorder Market Revenues & Volume, By Inhalers, 2021 - 2031F |
6.2.3 Togo Chronic Obstructive Pulmonary Disorder Market Revenues & Volume, By Nebulizers, 2021 - 2031F |
6.3 Togo Chronic Obstructive Pulmonary Disorder Market, By Disease Type |
6.3.1 Overview and Analysis |
6.3.2 Togo Chronic Obstructive Pulmonary Disorder Market Revenues & Volume, By Chronic Bronchitis, 2021 - 2031F |
6.3.3 Togo Chronic Obstructive Pulmonary Disorder Market Revenues & Volume, By Emphysema, 2021 - 2031F |
6.4 Togo Chronic Obstructive Pulmonary Disorder Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Togo Chronic Obstructive Pulmonary Disorder Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.4.3 Togo Chronic Obstructive Pulmonary Disorder Market Revenues & Volume, By Clinics, 2021 - 2031F |
6.4.4 Togo Chronic Obstructive Pulmonary Disorder Market Revenues & Volume, By Homecare, 2021 - 2031F |
7 Togo Chronic Obstructive Pulmonary Disorder Market Import-Export Trade Statistics |
7.1 Togo Chronic Obstructive Pulmonary Disorder Market Export to Major Countries |
7.2 Togo Chronic Obstructive Pulmonary Disorder Market Imports from Major Countries |
8 Togo Chronic Obstructive Pulmonary Disorder Market Key Performance Indicators |
8.1 Average time from COPD diagnosis to treatment initiation in Togo |
8.2 Number of COPD awareness campaigns conducted annually in Togo |
8.3 Percentage of COPD patients in Togo receiving regular follow-up care |
8.4 Availability of COPD medications in different regions of Togo |
8.5 Number of COPD-related hospital admissions in Togo due to exacerbations |
9 Togo Chronic Obstructive Pulmonary Disorder Market - Opportunity Assessment |
9.1 Togo Chronic Obstructive Pulmonary Disorder Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.2 Togo Chronic Obstructive Pulmonary Disorder Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.3 Togo Chronic Obstructive Pulmonary Disorder Market Opportunity Assessment, By Disease Type, 2021 & 2031F |
9.4 Togo Chronic Obstructive Pulmonary Disorder Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Togo Chronic Obstructive Pulmonary Disorder Market - Competitive Landscape |
10.1 Togo Chronic Obstructive Pulmonary Disorder Market Revenue Share, By Companies, 2024 |
10.2 Togo Chronic Obstructive Pulmonary Disorder Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here